149 related articles for article (PubMed ID: 31611391)
1. Wnt activator FOXB2 drives the neuroendocrine differentiation of prostate cancer.
Moparthi L; Pizzolato G; Koch S
Proc Natl Acad Sci U S A; 2019 Oct; 116(44):22189-22195. PubMed ID: 31611391
[TBL] [Abstract][Full Text] [Related]
2. FOXO3a modulates WNT/β-catenin signaling and suppresses epithelial-to-mesenchymal transition in prostate cancer cells.
Liu H; Yin J; Wang H; Jiang G; Deng M; Zhang G; Bu X; Cai S; Du J; He Z
Cell Signal; 2015 Mar; 27(3):510-8. PubMed ID: 25578861
[TBL] [Abstract][Full Text] [Related]
3. Forkhead box B2 inhibits the malignant characteristics of the pancreatic cancer cell line Panc-1 in vitro.
Fukuchi H; Hayashida Y; Inoue K; Sadamura Y
Genes Cells; 2019 Oct; 24(10):674-681. PubMed ID: 31433897
[TBL] [Abstract][Full Text] [Related]
4. YY1-Induced Upregulation of Long Noncoding RNA ARAP1-AS1 Promotes Cell Migration and Invasion in Colorectal Cancer Through the Wnt/β-Catenin Signaling Pathway.
Ye Y; Gu B; Wang Y; Shen S; Huang W
Cancer Biother Radiopharm; 2019 Oct; 34(8):519-528. PubMed ID: 31173500
[No Abstract] [Full Text] [Related]
5. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
Benhaj K; Akcali KC; Ozturk M
Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
[TBL] [Abstract][Full Text] [Related]
6.
Yang F; Fang E; Mei H; Chen Y; Li H; Li D; Song H; Wang J; Hong M; Xiao W; Wang X; Huang K; Zheng L; Tong Q
Cancer Res; 2019 Feb; 79(3):557-571. PubMed ID: 30563889
[TBL] [Abstract][Full Text] [Related]
7. Wnt/β-catenin signalling in prostate cancer.
Kypta RM; Waxman J
Nat Rev Urol; 2012 Aug; 9(8):418-28. PubMed ID: 22710668
[TBL] [Abstract][Full Text] [Related]
8. Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancer.
Terry S; Yang X; Chen MW; Vacherot F; Buttyan R
J Cell Biochem; 2006 Oct; 99(2):402-10. PubMed ID: 16741972
[TBL] [Abstract][Full Text] [Related]
9. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha.
Jiang YG; Luo Y; He DL; Li X; Zhang LL; Peng T; Li MC; Lin YH
Int J Urol; 2007 Nov; 14(11):1034-9. PubMed ID: 17956532
[TBL] [Abstract][Full Text] [Related]
10. Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells.
Uysal-Onganer P; Kawano Y; Caro M; Walker MM; Diez S; Darrington RS; Waxman J; Kypta RM
Mol Cancer; 2010 Mar; 9():55. PubMed ID: 20219091
[TBL] [Abstract][Full Text] [Related]
11. The lncRNA NEAT1 activates Wnt/β-catenin signaling and promotes colorectal cancer progression via interacting with DDX5.
Zhang M; Weng W; Zhang Q; Wu Y; Ni S; Tan C; Xu M; Sun H; Liu C; Wei P; Du X
J Hematol Oncol; 2018 Sep; 11(1):113. PubMed ID: 30185232
[TBL] [Abstract][Full Text] [Related]
12. A human- and male-specific protocadherin that acts through the wnt signaling pathway to induce neuroendocrine transdifferentiation of prostate cancer cells.
Yang X; Chen MW; Terry S; Vacherot F; Chopin DK; Bemis DL; Kitajewski J; Benson MC; Guo Y; Buttyan R
Cancer Res; 2005 Jun; 65(12):5263-71. PubMed ID: 15958572
[TBL] [Abstract][Full Text] [Related]
13. Wnt-3a regulates chondrocyte differentiation via c-Jun/AP-1 pathway.
Hwang SG; Yu SS; Lee SW; Chun JS
FEBS Lett; 2005 Aug; 579(21):4837-42. PubMed ID: 16099458
[TBL] [Abstract][Full Text] [Related]
14. The WNT7B protein promotes the migration and differentiation of human dental pulp cells partly through WNT/beta-catenin and c-Jun N-terminal kinase signalling pathways.
Lv H; Yang J; Wang C; Yu F; Huang D; Ye L
Arch Oral Biol; 2018 Mar; 87():54-61. PubMed ID: 29268145
[TBL] [Abstract][Full Text] [Related]
15. Targeted inhibition of T-cell factor activity promotes syndecan-2 expression and sensitization to doxorubicin in osteosarcoma cells and bone tumors in mice.
Dieudonné FX; Marion A; Marie PJ; Modrowski D
J Bone Miner Res; 2012 Oct; 27(10):2118-29. PubMed ID: 22550000
[TBL] [Abstract][Full Text] [Related]
16. Effects of WNT/beta-catenin pathway activation on signaling through T-cell factor and androgen receptor in prostate cancer cell lines.
Cronauer MV; Schulz WA; Ackermann R; Burchardt M
Int J Oncol; 2005 Apr; 26(4):1033-40. PubMed ID: 15753999
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Wnt/β-catenin signaling mediates ursolic acid-induced apoptosis in PC-3 prostate cancer cells.
Park JH; Kwon HY; Sohn EJ; Kim KA; Kim B; Jeong SJ; Song JH; Koo JS; Kim SH
Pharmacol Rep; 2013; 65(5):1366-74. PubMed ID: 24399733
[TBL] [Abstract][Full Text] [Related]
18. Yin Yang 1 promotes the neuroendocrine differentiation of prostate cancer cells via the non-canonical WNT pathway (FYN/STAT3).
Liu RJ; Xu ZP; Huang X; Xu B; Chen M
Clin Transl Med; 2023 Oct; 13(10):e1422. PubMed ID: 37771187
[TBL] [Abstract][Full Text] [Related]
19. FOXP1 potentiates Wnt/β-catenin signaling in diffuse large B cell lymphoma.
Walker MP; Stopford CM; Cederlund M; Fang F; Jahn C; Rabinowitz AD; Goldfarb D; Graham DM; Yan F; Deal AM; Fedoriw Y; Richards KL; Davis IJ; Weidinger G; Damania B; Major MB
Sci Signal; 2015 Feb; 8(362):ra12. PubMed ID: 25650440
[TBL] [Abstract][Full Text] [Related]
20. A switch from canonical to noncanonical Wnt signaling mediates early differentiation of human neural stem cells.
Bengoa-Vergniory N; Gorroño-Etxebarria I; González-Salazar I; Kypta RM
Stem Cells; 2014 Dec; 32(12):3196-208. PubMed ID: 25100239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
